Cross-sectional Survey of Zhejiang ECMO Application

A Study on the Application Status of Extracorporeal Membrane Oxygenation (ECMO) in Zhejiang Province

Extracorporeal lung oxygenation (ECMO) was first used in neonates in the 1970s and is now widely used to treat adult patients with intractable shock and respiratory failure who have failed various types of conventional life support. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients worldwide received ECMO in 2019. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients were treated with ECMO worldwide in 2019, including 25,631 VV-ECOM, 12,836 VA, and 5086 ECPR. The number of ECMO cases and hospitals in Zhejiang province are increasing year by year, and they play an irreplaceable role in various critical care resuscitation, especially in response to public emergencies, but there is a lack of precise data on the current status of ECMO implementation. This study aims to investigate the implementation of ECMO, problems and needs of hospitals at all levels in Zhejiang Province, and provide reference for further improving the capacity and quality of ECMO application in the province.

Study Overview

• Status: Not yet recruiting
• Conditions: Extracorporeal Membrane Oxygenation; Cardiopulmonary Resuscitation; Epidemiology
• Intervention / Treatment: Other

Detailed Description

This is a multicenter cross-sectional survey study ,was conducted jointly by the Zhejiang Emergency Medicine Quality Control Center, the Zhejiang Medical Emergency Medicine Branch and the Zhejiang Physicians Association Emergency Physicians Branch. The survey covers the general situation and ECMO implementation in general public hospitals at the county and district level in Zhejiang Province, including people's hospitals, Chinese medicine hospitals and above.

• Study Type: Observational
• Enrollment (Anticipated): 1

Contacts and Locations

• Study Contact: Name: Mao Zhang, MD; Phone Number: ０８６ 5718778465; Email: zmhz@hotmail.com

Study Locations

• China
  • Zhejiang
    • Hangzhou, Zhejiang, China, 310009
      • Second Affiliated Hospital, Zhejiang University School of Medicine & Institute of Emergency Medicine, Zhejiang University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All general hospitals at the first people's hospital and above at the county and district level in Zhejiang Province

Description

Inclusion Criteria:

• All general hospitals at the first people's hospital and above at the county and district level in Zhejiang Province

Exclusion Criteria:

• Hospitals that explicitly do not wish to participate

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Contains the general description of the hospital	including hospital level, nature, number of approved beds, total number of outpatient and emergency departments in 2019, number of discharges, and number of operations	1 year
ECMO configuration	ECMO equipment manufacturers, models, number of ECMOs, belonging departments, and those who are proficient in ECMO Health care team	1 year
ECMO development status	first case development time, independent hospital development time, number, type and number of weaning machines carried out in 2019, operating costs, etc	1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Zhejiang Hospital's Cognitive Status of ECMO Development	The surveyed unit's views on ECMO's role in hospitals, discipline development and the rescue of critically ill patients, the main difficulties encountered in carrying out ECMO, and the need for ECMO training and quality control	1 year

Collaborators and Investigators

• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Collaborators: First People's Hospital of Hangzhou; Ningbo Medical Center Lihuili Hospital; Sir Run Run Shaw Hospital; Red Cross Hospital, Hangzhou, China; Zhejiang Provincial People's Hospital; The First Affiliated Hospital of Zhejiang Chinese Medical University; The Affiliated Hospital of Hangzhou Normal University; Zhejiang Hospital; Hangzhou Third People's Hospital; Hangzhou Children's Hospital; The First Hospital of Fuyang District, Hangzhou; The First Hospital of Xiaoshan District, Hangzhou; The First Hospital of Linping District, Hangzhou; The First Hospital of Lin'an District, Hangzhou; The First Hospital of Tonglu County, Hangzhou; The First Hospital of Jiande County, Hangzhou; The First Hospital of Chun'an County, Hangzhou; Affiliated Cixi Hospital of Wenzhou Medical University; Ningbo First People's Hospital
• Investigators: Principal Investigator: Bin Zhang, masters, Departmental staff

Study record dates

Study Major Dates

• Study Start (Anticipated): August 1, 2021
• Primary Completion (Anticipated): August 30, 2021
• Study Completion (Anticipated): September 1, 2021

Study Registration Dates

• First Submitted: June 7, 2021
• First Submitted That Met QC Criteria: July 15, 2021
• First Posted (Actual): July 28, 2021

Study Record Updates

• Last Update Posted (Actual): July 28, 2021
• Last Update Submitted That Met QC Criteria: July 15, 2021
• Last Verified: June 1, 2021

More Information

Terms related to this study

• Keywords: Epidemiology; Extracorporeal membrane oxygenation
• Other Study ID Numbers: I2021001538

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No